Outcome measure | No prior ETN/IFX | Prior ETN or IFX or both |
---|---|---|
 | (n = 376) | (n = 66) |
TJC (0 to 78) | Â | Â |
   Baseline | 16 | 15 |
 | 10, 27 | 8, 25 |
   Change, Baseline to week 12 | -10 | -10 |
 | -17, -5 | -16, -3 |
SJC (0 to 76) | Â | Â |
   Baseline | 9 | 7 |
 | 5, 13 | 5, 11 |
   Change, Baseline to week 12 | -7 | -5 |
 | -10, -3 | -8, -3 |
HAQ DI (0 to 3) | Â | Â |
   Baseline | 1.25 | 1.44 |
 | 0.75, 1.63 | 1.00, 1.75 |
   Change, Baseline to week 12 | -0.50 | -0.50 |
 | -0.88, -0.13 | -0.75, -0.25 |
Patients with nail psoriasis (NAPSI ≥ 1) | n = 223 | n = 36 |
NAPSI (0 to 80) | Â | Â |
   Baseline | 14 | 18 |
 | 5, 30 | 10, 37 |
   Change, Baseline to week 12 | -6 | -6 |
 | -14, -2 | -15, -1 |